Comparing two lipid-lowering treatments for asymptomatic intracranial stenosis
This study compares two levels of cholesterol-lowering treatment to see which is more effective at preventing strokes and other heart events in people who have narrowing in a brain artery but have not had a stroke or mini-stroke yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 80 years old.
- You must have at least 50% narrowing in a major brain artery, confirmed by imaging.
- Your LDL cholesterol must be 100-190 mg/dL or you must be on cholesterol-lowering therapy.
- You must have at least one vascular risk factor like high blood pressure, diabetes, smoking, family history of early heart disease, or chronic kidney disease.
- You cannot have had a prior stroke, TIA, or certain heart conditions.
- You cannot have severe liver or kidney disease, be pregnant, or be taking other investigational drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
This trial is testing an interventional treatment for people who have severe narrowing (70-99%) in a major brain artery that has caused a stroke or mini-stroke in the past year. The goal is to see if this treatment can help prevent future strokes.
This trial tests whether a catheter-based procedure (angioplasty and stenting guided by blood-flow measurements) plus medications works better than medications alone. It’s for people who recently had a TIA or stroke caused by a severe narrowing in certain brain arteries.
This study looks at strategies to improve cholesterol treatment in adults whose brain arteries are narrowed and who have had symptoms. Better cholesterol management may help reduce future problems related to this condition.
This trial tests whether placing a stent in a severely narrowed brain artery, along with aggressive medication, can prevent another stroke better than medication alone. It is for people who had a mild stroke within the last 30 days due to a 70-99% blockage in a major brain artery.
This trial tests whether adding a PCSK9 inhibitor to a statin is better than a statin alone for people with mild-to-moderate narrowing of the carotid artery (the main artery in the neck). It looks at how well these treatments slow plaque buildup and prevent strokes.
Hear when a new Intracranial Atherosclerosis ICAS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.